Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON21185Active, not recruiting
Trial of dexamethasone in retinal detachment (2 arms). Primary endpoint: Incidence of proliferative vitreoretinopathy. Started Nov 2002; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON21185.